Friday, May 24, 2013

New Details on the Clinical Collaboration Congress!

The organizers of the leading Partnerships in Clinical Trials event are proud to present the all-new Clinical Collaboration Congress. This interactive event experience was developed for clinical leaders, like you, to collaborate with your peers on how to change the way the industry does business. Forward-thinking collaborative minds combine with interactive discussions that make you part of the learning experience for the highest level of engagement.


What makes CCC Unique?
  • • Collaboration is key. CCC is the only event with a focus on cross-industry collaborations, consortia and new partnering paradigms to challenge the current clinical development model.
  • • Location, location, location. We're in biotech's backyard, so you'll travel less - or not at all, but get all 3 days of content and networking.
  • • Smaller is better. Don't get lost in the crowd! CCC brings you a dedicated track and pre-conference summit to address specific issues burdening small to mid-size pharmaceutical, biotech, and medical device companies.
  • • The ONLY place to meet all of your Labs vendors are under 1 roof. We're bringing back the Partnering with Labs track and the Logistics Task Force where stakeholders will tackle the biggest cost drivers and quality killers impacting clinical logistics.

Say Goodbye To The Same Old Presentation Formats!
In creating this agenda, we kept 3 things in mind - learn, engage and partner. CCC is proud to introduce unique formats that immerse you into interactive discussions that promote the highest level of engagement through Think Tank Sessions and a Tech Town Hall hosted by Marc Foster of Transparency Life Sciences.

Would you like to join us for this new, collaborative experience taking place September 25-27, 2013 in Boston? As a reader of this blog, when you register to join us and mention code XP1825BLOG, you’ll save 15% off the standard rate! What to join us for free? Check out our option to be a guest blogger.  Have any questions? Feel free to email Jennifer Pereira.




No comments: